| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-like protein-specific endopeptidase activity | 3.70e-05 | 5 | 39 | 2 | GO:0070137 | |
| GeneOntologyMolecularFunction | SUMO-specific endopeptidase activity | 3.70e-05 | 5 | 39 | 2 | GO:0070139 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF599 ZNF12 ZNF814 ZNF17 KLF18 ZNF362 ZNF33B ZNF649 USP3 ZNF644 YY2 | 7.57e-05 | 1459 | 39 | 11 | GO:0000977 |
| GeneOntologyMolecularFunction | deSUMOylase activity | 7.76e-05 | 7 | 39 | 2 | GO:0016929 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF12 ZNF814 ZNF17 KLF18 ZNF362 ZNF33B ZNF649 USP3 ZNF644 YY2 | 1.02e-04 | 1244 | 39 | 10 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF12 ZNF814 ZNF17 KLF18 ZNF362 ZNF33B ZNF649 USP3 ZNF644 YY2 | 1.22e-04 | 1271 | 39 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 1.45e-04 | 137 | 39 | 4 | GO:0019783 | |
| GeneOntologyMolecularFunction | peptidase activity | 2.42e-04 | 654 | 39 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 5.24e-04 | 192 | 39 | 4 | GO:0008234 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.51e-03 | 891 | 39 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | metallocarboxypeptidase activity | 1.67e-03 | 31 | 39 | 2 | GO:0004181 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.81e-03 | 1189 | 39 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | fibronectin binding | 2.50e-03 | 38 | 39 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | carboxypeptidase activity | 4.13e-03 | 49 | 39 | 2 | GO:0004180 | |
| GeneOntologyMolecularFunction | integrin binding | 4.80e-03 | 175 | 39 | 3 | GO:0005178 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 5.24e-03 | 1412 | 39 | 8 | GO:0000981 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 ZMAT2 YY2 | 1.86e-07 | 775 | 37 | 11 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 ZMAT2 YY2 | 1.91e-07 | 777 | 37 | 11 | PS00028 |
| Domain | Znf_C2H2-like | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 ZMAT2 YY2 | 2.43e-07 | 796 | 37 | 11 | IPR015880 |
| Domain | Znf_C2H2 | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 ZMAT2 YY2 | 2.72e-07 | 805 | 37 | 11 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 ZMAT2 YY2 | 2.83e-07 | 808 | 37 | 11 | SM00355 |
| Domain | - | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 YY2 | 5.40e-07 | 679 | 37 | 10 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF599 ZNF12 ZNF814 ZNF17 ZNF362 ZNF33B ZNF649 DPF3 ZNF644 YY2 | 6.60e-07 | 694 | 37 | 10 | IPR013087 |
| Domain | EGF_1 | 9.96e-06 | 255 | 37 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.14e-05 | 261 | 37 | 6 | IPR013032 | |
| Domain | Requiem/DPF_N_dom | 1.14e-05 | 3 | 37 | 2 | IPR025750 | |
| Domain | Requiem_N | 1.14e-05 | 3 | 37 | 2 | PF14051 | |
| Domain | EGF_2 | 1.24e-05 | 265 | 37 | 6 | PS01186 | |
| Domain | zf-C2H2 | 5.13e-05 | 693 | 37 | 8 | PF00096 | |
| Domain | KRAB | 6.69e-05 | 358 | 37 | 6 | PS50805 | |
| Domain | KRAB | 6.69e-05 | 358 | 37 | 6 | PF01352 | |
| Domain | KRAB | 7.91e-05 | 369 | 37 | 6 | SM00349 | |
| Domain | Peptidase_C48 | 7.97e-05 | 7 | 37 | 2 | PF02902 | |
| Domain | ULP_PROTEASE | 7.97e-05 | 7 | 37 | 2 | PS50600 | |
| Domain | Peptidase_C48_C | 7.97e-05 | 7 | 37 | 2 | IPR003653 | |
| Domain | KRAB | 8.03e-05 | 370 | 37 | 6 | IPR001909 | |
| Domain | EGF_3 | 9.48e-05 | 235 | 37 | 5 | PS50026 | |
| Domain | EGF | 9.48e-05 | 235 | 37 | 5 | SM00181 | |
| Domain | EGF | 1.10e-04 | 126 | 37 | 4 | PF00008 | |
| Domain | EGF-like_dom | 1.24e-04 | 249 | 37 | 5 | IPR000742 | |
| Domain | EGF_extracell | 2.27e-04 | 60 | 37 | 3 | IPR013111 | |
| Domain | EGF_2 | 2.27e-04 | 60 | 37 | 3 | PF07974 | |
| Domain | EGF_3 | 2.49e-04 | 12 | 37 | 2 | PF12947 | |
| Domain | EGF_dom | 2.49e-04 | 12 | 37 | 2 | IPR024731 | |
| Domain | Growth_fac_rcpt_ | 2.50e-04 | 156 | 37 | 4 | IPR009030 | |
| Domain | EGF_CA | 6.54e-04 | 86 | 37 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 9.28e-04 | 97 | 37 | 3 | IPR018097 | |
| Domain | EGF_CA | 9.85e-04 | 99 | 37 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.01e-03 | 100 | 37 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.20e-03 | 106 | 37 | 3 | IPR000152 | |
| Domain | cEGF | 1.20e-03 | 26 | 37 | 2 | IPR026823 | |
| Domain | cEGF | 1.20e-03 | 26 | 37 | 2 | PF12662 | |
| Domain | EGF_CA | 1.80e-03 | 122 | 37 | 3 | SM00179 | |
| Domain | - | 1.82e-03 | 449 | 37 | 5 | 3.30.40.10 | |
| Domain | EGF-like_Ca-bd_dom | 1.88e-03 | 124 | 37 | 3 | IPR001881 | |
| Domain | Znf_RING/FYVE/PHD | 2.00e-03 | 459 | 37 | 5 | IPR013083 | |
| Domain | RING | 3.01e-03 | 305 | 37 | 4 | SM00184 | |
| Domain | zf-C2H2_6 | 3.34e-03 | 314 | 37 | 4 | PF13912 | |
| Domain | PSI | 3.74e-03 | 46 | 37 | 2 | SM00423 | |
| Domain | Znf_RING | 3.82e-03 | 326 | 37 | 4 | IPR001841 | |
| Domain | USP_CS | 7.56e-03 | 66 | 37 | 2 | IPR018200 | |
| Domain | USP_1 | 8.47e-03 | 70 | 37 | 2 | PS00972 | |
| Domain | UCH | 8.71e-03 | 71 | 37 | 2 | PF00443 | |
| Domain | USP_2 | 8.71e-03 | 71 | 37 | 2 | PS00973 | |
| Domain | USP_3 | 8.95e-03 | 72 | 37 | 2 | PS50235 | |
| Domain | USP_dom | 8.95e-03 | 72 | 37 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 8.95e-03 | 72 | 37 | 2 | IPR001394 | |
| Domain | PHD | 9.68e-03 | 75 | 37 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 1.07e-02 | 79 | 37 | 2 | IPR019787 | |
| Domain | PHD | 1.34e-02 | 89 | 37 | 2 | SM00249 | |
| Domain | Znf_PHD | 1.40e-02 | 91 | 37 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.52e-02 | 95 | 37 | 2 | PS50016 | |
| Pathway | REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED | 6.10e-05 | 6 | 29 | 2 | M27225 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 6.29e-05 | 38 | 29 | 3 | MM14874 | |
| Pathway | REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED | 8.53e-05 | 7 | 29 | 2 | MM14928 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 9.14e-05 | 43 | 29 | 3 | M53 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.19e-04 | 47 | 29 | 3 | M646 | |
| Pathway | REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO | 1.82e-04 | 10 | 29 | 2 | M27235 | |
| Pathway | REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO | 2.22e-04 | 11 | 29 | 2 | MM14937 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.97e-04 | 76 | 29 | 3 | MM14867 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.17e-04 | 77 | 29 | 3 | MM14670 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.90e-04 | 85 | 29 | 3 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 9.25e-04 | 94 | 29 | 3 | M1041 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.39e-03 | 27 | 29 | 2 | M27217 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.78e-03 | 118 | 29 | 3 | MM15588 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.83e-03 | 31 | 29 | 2 | M39522 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.95e-03 | 32 | 29 | 2 | MM14854 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.33e-03 | 35 | 29 | 2 | M47969 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.60e-03 | 37 | 29 | 2 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.89e-03 | 39 | 29 | 2 | MM14601 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 3.02e-03 | 142 | 29 | 3 | M48257 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 3.34e-03 | 42 | 29 | 2 | M48237 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.66e-03 | 44 | 29 | 2 | M26969 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 15062093 | ||
| Pubmed | Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer. | 1.23e-06 | 2 | 39 | 2 | 21091771 | |
| Pubmed | Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer. | 1.23e-06 | 2 | 39 | 2 | 27178176 | |
| Pubmed | 1.23e-06 | 2 | 39 | 2 | 24196834 | ||
| Pubmed | Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. | 1.23e-06 | 2 | 39 | 2 | 24107997 | |
| Pubmed | SENP1 and SENP2 affect spatial and temporal control of sumoylation in mitosis. | 1.23e-06 | 2 | 39 | 2 | 24048451 | |
| Pubmed | Two distinct sites in Nup153 mediate interaction with the SUMO proteases SENP1 and SENP2. | 3.67e-06 | 3 | 39 | 2 | 22688647 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18765789 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 8812431 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15336554 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 18062611 | ||
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 5.73e-06 | 31 | 39 | 3 | 2288909 | |
| Pubmed | SENP1 participates in the dynamic regulation of Elk-1 SUMOylation. | 7.34e-06 | 4 | 39 | 2 | 20337593 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 17591783 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 25891951 | ||
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 12807887 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 25412743 | ||
| Pubmed | 1.83e-05 | 6 | 39 | 2 | 17158881 | ||
| Pubmed | Zinc deficiency induces abnormal development of the myocardium by promoting SENP5 overexpression. | 1.83e-05 | 6 | 39 | 2 | 33211757 | |
| Pubmed | 2.46e-05 | 50 | 39 | 3 | 23658023 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 27256716 | ||
| Pubmed | 2.56e-05 | 7 | 39 | 2 | 8798654 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 37029301 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 3.42e-05 | 8 | 39 | 2 | 23055981 | |
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 15896780 | ||
| Pubmed | 3.42e-05 | 8 | 39 | 2 | 16608850 | ||
| Pubmed | 5.06e-05 | 181 | 39 | 4 | 37372979 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 22334708 | ||
| Pubmed | 6.70e-05 | 11 | 39 | 2 | 21965678 | ||
| Pubmed | Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis. | 8.03e-05 | 12 | 39 | 2 | 30612578 | |
| Pubmed | The Mohawk homeobox gene is a critical regulator of tendon differentiation. | 9.48e-05 | 13 | 39 | 2 | 20498044 | |
| Pubmed | 1.11e-04 | 14 | 39 | 2 | 2014798 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 23785148 | ||
| Pubmed | 1.27e-04 | 15 | 39 | 2 | 17640523 | ||
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 1.27e-04 | 15 | 39 | 2 | 17920018 | |
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 15767674 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 1.85e-04 | 18 | 39 | 2 | 23698369 | |
| Pubmed | Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity. | 1.85e-04 | 18 | 39 | 2 | 18651661 | |
| Pubmed | SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. | 1.85e-04 | 18 | 39 | 2 | 17981124 | |
| Pubmed | 2.07e-04 | 19 | 39 | 2 | 16932743 | ||
| Pubmed | Signal peptide prediction based on analysis of experimentally verified cleavage sites. | 2.17e-04 | 264 | 39 | 4 | 15340161 | |
| Pubmed | 2.54e-04 | 21 | 39 | 2 | 22479202 | ||
| Pubmed | 2.79e-04 | 22 | 39 | 2 | 35640597 | ||
| Pubmed | 2.79e-04 | 22 | 39 | 2 | 27527664 | ||
| Pubmed | Discovery of six new susceptibility loci and analysis of pleiotropic effects in leprosy. | 2.79e-04 | 22 | 39 | 2 | 25642632 | |
| Pubmed | 3.33e-04 | 24 | 39 | 2 | 12215535 | ||
| Pubmed | 3.33e-04 | 24 | 39 | 2 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 3.33e-04 | 24 | 39 | 2 | 10078207 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 3.59e-04 | 123 | 39 | 3 | 26912792 | |
| Pubmed | 3.91e-04 | 26 | 39 | 2 | 10778858 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 4.55e-04 | 28 | 39 | 2 | 12192000 | |
| Pubmed | 5.23e-04 | 30 | 39 | 2 | 31043422 | ||
| Pubmed | ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation. | 5.23e-04 | 30 | 39 | 2 | 32882513 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 5.66e-04 | 608 | 39 | 5 | 36089195 | |
| Pubmed | 7.12e-04 | 35 | 39 | 2 | 32504627 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 4.74e-04 | 1192 | 39 | 6 | chr19q13 | |
| Cytoband | 19q13.11 | 6.80e-04 | 45 | 39 | 2 | 19q13.11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.92e-06 | 718 | 26 | 8 | 28 | |
| GeneFamily | SUMO specific peptidases | 4.16e-05 | 7 | 26 | 2 | 984 | |
| GeneFamily | Ubiquitin specific peptidases | 2.92e-03 | 56 | 26 | 2 | 366 | |
| GeneFamily | PHD finger proteins | 7.37e-03 | 90 | 26 | 2 | 88 | |
| Coexpression | GSE3039_B2_VS_B1_BCELL_UP | 8.58e-06 | 199 | 37 | 5 | M6450 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 1.25e-05 | 168 | 38 | 4 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-05 | 182 | 38 | 4 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 189 | 38 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 189 | 38 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 189 | 38 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-05 | 191 | 38 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 192 | 38 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 192 | 38 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 192 | 38 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.21e-05 | 194 | 38 | 4 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | 61d7dd0a78942b069c3f5e75044368dc00e6e8e6 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.48e-05 | 200 | 38 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | 4fe3b2d80c567c18621bff3341f9a73578c81621 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 200 | 38 | 4 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.89e-04 | 131 | 38 | 3 | 9ca209a8652aae603c4a867ea06b06ac51e7d189 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.76e-04 | 149 | 38 | 3 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.34e-04 | 159 | 38 | 3 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-04 | 160 | 38 | 3 | 984990be02642a562f0c60ea99c01f005e7c02c2 | |
| ToppCell | CV-Mild-4|CV / Virus stimulation, Condition and Cluster | 3.40e-04 | 160 | 38 | 3 | be89efeeecb0de96ce136a7a62738f15dc0badb2 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.52e-04 | 162 | 38 | 3 | 74cd0de957fdbe527656befd61f67d6814ce9e98 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-1|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.72e-04 | 165 | 38 | 3 | 2ca1154a8692af311d99a4d3aa2f2ac3d23a4310 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.92e-04 | 168 | 38 | 3 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 171 | 38 | 3 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 4.13e-04 | 171 | 38 | 3 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 171 | 38 | 3 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.13e-04 | 171 | 38 | 3 | 87d652afbb375f8ee50e5faecf6085630cd2163c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.27e-04 | 173 | 38 | 3 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.27e-04 | 173 | 38 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | Healthy_Control-Lymphoid-NK-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.34e-04 | 174 | 38 | 3 | 5dddb822fa51b4020e4d9318acacd19c726091d6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 175 | 38 | 3 | f0c2eb82e17e8aec2cfa5d83169178f409cc1abc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 175 | 38 | 3 | 910a075ccaf79de22338ecf321fa0a867f3d7d75 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.49e-04 | 176 | 38 | 3 | 0f55de48bbc396c187f2a7d1d7da20862c715f9e | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 178 | 38 | 3 | f2002a5c4758d0af6c1880ca12f0af0d5e8888e4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-04 | 180 | 38 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-04 | 181 | 38 | 3 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.87e-04 | 181 | 38 | 3 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 182 | 38 | 3 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 182 | 38 | 3 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.95e-04 | 182 | 38 | 3 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-04 | 185 | 38 | 3 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-04 | 185 | 38 | 3 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.19e-04 | 185 | 38 | 3 | 1ac6a32cc56d5d819649bdd99518e2ead0eead4c | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 185 | 38 | 3 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.44e-04 | 188 | 38 | 3 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.44e-04 | 188 | 38 | 3 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-04 | 188 | 38 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 5.52e-04 | 189 | 38 | 3 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 189 | 38 | 3 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.52e-04 | 189 | 38 | 3 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.52e-04 | 189 | 38 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.52e-04 | 189 | 38 | 3 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-04 | 189 | 38 | 3 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-04 | 190 | 38 | 3 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.61e-04 | 190 | 38 | 3 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-04 | 190 | 38 | 3 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.69e-04 | 191 | 38 | 3 | 219e38df321cd41e2d0861ca01ab0d71bbbd4d9b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.69e-04 | 191 | 38 | 3 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.69e-04 | 191 | 38 | 3 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.78e-04 | 192 | 38 | 3 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-04 | 192 | 38 | 3 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.78e-04 | 192 | 38 | 3 | e6d115143ced6a0d9fe7c98acd3f730bac83f66b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.78e-04 | 192 | 38 | 3 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.78e-04 | 192 | 38 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-04 | 193 | 38 | 3 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-04 | 193 | 38 | 3 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-04 | 193 | 38 | 3 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 5.96e-04 | 194 | 38 | 3 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-04 | 194 | 38 | 3 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-04 | 194 | 38 | 3 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-04 | 194 | 38 | 3 | d47e3c7b22444aef0c7a37bc8cd8853b590a56dd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 5.96e-04 | 194 | 38 | 3 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-04 | 194 | 38 | 3 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-04 | 194 | 38 | 3 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 5.96e-04 | 194 | 38 | 3 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 5.96e-04 | 194 | 38 | 3 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 5.96e-04 | 194 | 38 | 3 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-04 | 194 | 38 | 3 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 5.96e-04 | 194 | 38 | 3 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.05e-04 | 195 | 38 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.05e-04 | 195 | 38 | 3 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-04 | 195 | 38 | 3 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | (0)_NK/T_cells-(0)_NK_T_CD8_Cytotoxic|(0)_NK/T_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 6.05e-04 | 195 | 38 | 3 | 13717c6e42882162445bc1b1445d66efcb68e19d | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.14e-04 | 196 | 38 | 3 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.14e-04 | 196 | 38 | 3 | 67400193ba469cf4d939e94f5ed94995e384bc07 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.14e-04 | 196 | 38 | 3 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Airway_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.23e-04 | 197 | 38 | 3 | 233caeee200ca905900226f85426e084caf290fb | |
| ToppCell | COVID-19-COVID-19_Convalescent-Others-HSPC|COVID-19_Convalescent / Disease, condition lineage and cell class | 6.23e-04 | 197 | 38 | 3 | c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.23e-04 | 197 | 38 | 3 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.23e-04 | 197 | 38 | 3 | b4554353c56e220bae31ee3c8aa222674dd0b18c | |
| Computational | Genes in the cancer module 412. | 3.67e-04 | 13 | 24 | 2 | MODULE_412 | |
| Computational | Genes in the cancer module 275. | 5.63e-04 | 16 | 24 | 2 | MODULE_275 | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 7.23e-07 | 197 | 37 | 6 | 5565_UP | |
| Disease | pulse pressure measurement | 4.23e-05 | 1392 | 37 | 9 | EFO_0005763 | |
| Disease | fasting blood insulin measurement | 8.98e-05 | 69 | 37 | 3 | EFO_0004466 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 2.87e-04 | 20 | 37 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | triglyceride measurement, physical activity | 8.37e-04 | 34 | 37 | 2 | EFO_0003940, EFO_0004530 | |
| Disease | attempted suicide | 1.44e-03 | 178 | 37 | 3 | EFO_0004321 | |
| Disease | urinary albumin to creatinine ratio | 1.47e-03 | 179 | 37 | 3 | EFO_0007778 | |
| Disease | chronic obstructive pulmonary disease | 1.60e-03 | 688 | 37 | 5 | EFO_0000341 | |
| Disease | reticulocyte count | 1.77e-03 | 1045 | 37 | 6 | EFO_0007986 | |
| Disease | Crohn's disease | 2.20e-03 | 441 | 37 | 4 | EFO_0000384 | |
| Disease | magnesium measurement | 3.12e-03 | 66 | 37 | 2 | EFO_0004845 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESMGYHFCDSLLDYC | 556 | Q8NEM8 | |
| AEMCCYCFDVLYCHL | 106 | Q6DCA0 | |
| LYMDYLCFRALCCKG | 11 | Q9NXU5 | |
| LFCDDCDRGYHMYCL | 341 | Q92782 | |
| CADMKRCSYYETCAT | 536 | Q99490 | |
| DMCLFDMGGEYYCFA | 271 | P12955 | |
| AMAYDCYVAICDPLC | 116 | Q8NGJ3 | |
| CCCAAMIYLGYCFCG | 416 | Q8TDD5 | |
| LLFCDDCDRGYHMYC | 331 | Q92784 | |
| DANCCLDAICYYYMA | 266 | Q9HC97 | |
| MLCAGYFDCKSDACQ | 581 | Q04756 | |
| YCEDIDECAAKMHYC | 431 | Q92832 | |
| DDCMCVEGLRCYAKF | 306 | Q8NBI3 | |
| YCDAAHCVATGYMCK | 31 | Q13145 | |
| YRCLCYDGFMASEDM | 1261 | P35555 | |
| YCECDDFSCVRYKGE | 546 | P05106 | |
| CTYEDCKMSYSKACH | 966 | A0A0U1RQI7 | |
| CGGLAMYECRECYDD | 791 | Q9NQC7 | |
| CMFLGEECCYYINES | 466 | P60507 | |
| VMGSYECCCKEGFFL | 146 | Q9NQ36 | |
| YCNECMLDPDCGFCY | 441 | Q96QE2 | |
| SDCGMFTCKYADYIS | 546 | Q9HC62 | |
| SDCGMFACKYADCIT | 601 | Q9P0U3 | |
| DGKGCEMICYCNFSE | 61 | O75711 | |
| EYYCFDKSMCECFDS | 541 | Q96JS3 | |
| SICFCEKLGSECMYF | 221 | Q9UBS8 | |
| ECMYFLECRHVYCKA | 231 | Q9UBS8 | |
| PYECNECGKACRYMA | 226 | Q96NL3 | |
| YECYECGKSFCMNSH | 441 | Q06732 | |
| CSYSGCEKMFRDYAA | 256 | O15391 | |
| CEQGFKGYDCSDMSC | 456 | P24821 | |
| YYCEDDGKLLCVMCR | 111 | Q12899 | |
| DKRYYCCEECNFMAV | 521 | Q9H582 | |
| MDCSSYSTYCYRCDD | 86 | Q9Y6I4 | |
| YCCSMCGRAYTSETY | 371 | Q5T0B9 | |
| GEKAYECYECGKCFS | 601 | P17014 | |
| ECYECGKCFSQMSYL | 606 | P17014 | |
| RPFYCCECGKFFMDS | 356 | P17021 | |
| CYVCCECGKSFSKYA | 241 | B7Z6K7 | |
| EMGGYYCNVCDCVVK | 76 | Q96NC0 | |
| GCDECEKAYFYMSCL | 431 | Q9BS31 |